These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 7606840
21. A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteine. Evert B, Griese EU, Eichelbaum M. Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):434-9. PubMed ID: 7845481 [Abstract] [Full Text] [Related]
23. Debrisoquine polymorphism: novel CYP2D6 gene Bam HI restriction fragment length polymorphism in the Ngawbé Guaymí Indian of Panama. Petersen DD, Kong AN, Jorge LF, Nebert DW, Arias TD. Pharmacogenetics; 1991 Dec; 1(3):136-42. PubMed ID: 1688244 [Abstract] [Full Text] [Related]
29. Molecular genetic analysis of the cytochrome P450-debrisoquine hydroxylase locus and association with cancer susceptibility. Smith CA, Moss JE, Gough AC, Spurr NK, Wolf CR. Environ Health Perspect; 1992 Nov; 98():107-12. PubMed ID: 1486838 [Abstract] [Full Text] [Related]
36. A new CYP2D6 allele with a nine base insertion in exon 9 in a Japanese population associated with poor metabolizer phenotype. Yokoi T, Kosaka Y, Chida M, Chiba K, Nakamura H, Ishizaki T, Kinoshita M, Sato K, Gonzalez FJ, Kamataki T. Pharmacogenetics; 1996 Oct 01; 6(5):395-401. PubMed ID: 8946471 [Abstract] [Full Text] [Related]